MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacadv.2026.103122

Медицинская библиотека · JACC. Advances · 2026

INSIGHT Model: Explainable Artificial Intelligence for Real-World EHR-Based Screening of Transthyretin Amyloidosis Cardiomyopathy.

Arora Akshay, Khan Muhammad Shahzeb, Sunderman Cynthia, Baldwin Nicole, Bennett Monica, Bomar Vee Anne, Cross Lisa, da Graca Briget, Ettlinger Jason, Gottlieb Robert L, Hammonds Kendall, Mack Michael, Masri Ahmad, Papas Mia, Priest Elisa L, Shaver Courtney, Venditto John, Butler Javed

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Transthyretin amyloidosis (ATTR) diagnoses are frequently delayed or missed, attenuating treatment benefit.

OBJECTIVES

The authors developed an explainable artificial intelligence screening tool to identify high-risk patients who should be considered for diagnostic testing for ATTR-cardiomyopathy (ATTR-CM) from an unselected heart failure (HF) population.

METHODS

Electronic health record data (April 2020-March 2023) were used to identify patients with suspected ATTR-CM in an HF cohort. Natural language processing with Named Entity Recognition processed unstructured clinical, echocardiographic, and electrocardiographic data. Clinical ModernBERT predicted suspected ATTR-CM. Local interpretable model-agnostic explanations were provided. The authors examined sensitivity, specificity, positive predictive value, negative predictive value, F1 score, area under the receiver-operating characteristic curve, and key model predictors.

RESULTS

This study included 100,290 patients with HF (mean age: 71.6 ± 14.3 years; 47.3% female; 76.2% White; 18.2% Black; 89.7% non-Hispanic). The Clinical ModernBERT model, INSIGHT-CM, identified suspected ATTR-CM (n = 1,108; prevalence 1.2%) with sensitivity 77.5% (95% CI: 75.9%-82.8%), specificity 94.7% (95% CI: 94.4%-95.0%), positive predictive value 19.9% (95% CI: 17.6%-22.36%), negative predictive value 99.6% (95% CI: 99.5%-99.7%), and area under the receiver-operating characteristic curve 92.4% (95% CI: 90.5%-94.3%).

CONCLUSIONS

In an unselected HF population with 1% prevalence of suspected ATTR-CM, INSIGHT-CM identified patients among whom 1 in 5 fit the pattern for suspected ATTR-CM, offering meaningful opportunities to improve timely diagnosis and treatment.

Для цитирования: Arora Akshay, Khan Muhammad Shahzeb, Sunderman Cynthia, Baldwin Nicole, Bennett Monica, Bomar Vee Anne, Cross Lisa, da Graca Briget, Ettlinger Jason, Gottlieb Robert L, Hammonds Kendall, Mack Michael, Masri Ahmad, Papas Mia, Priest Elisa L, Shaver Courtney, Venditto John, Butler Javed. INSIGHT Model: Explainable Artificial Intelligence for Real-World EHR-Based Screening of Transthyretin Amyloidosis Cardiomyopathy.. JACC. Advances. 2026. DOI: 10.1016/j.jacadv.2026.103122.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.